Stay updated on Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page for NCT03576963 now renders a 403 Forbidden response. It replaces the study content with a 403 message and a minimal header, blocking access to the study details.
    Difference
    19%
    Check dated 2026-09-23T01:09:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 has been added, replacing the previous v3.6.6. This signals a backend/page revision rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:09:13.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.5 to v3.6.6 in the footer, indicating a new version of the site’s software; this change does not modify core content or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-09-01T19:18:29.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.4 to v3.6.5, signaling a minor page update. No study content or user-facing details appear to be changed.
    Difference
    0.1%
    Check dated 2026-08-11T06:19:36.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor update to the page software.
    Difference
    0.1%
    Check dated 2026-07-28T05:13:48.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.2 to v3.6.3, indicating a newer version of the page. This is a routine maintenance update and does not affect study content or visible information.
    Difference
    0.1%
    Check dated 2026-07-06T16:14:52.000Z thumbnail image

Stay in the know with updates to Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous DCs+Tumor Lysate+Nivolumab in Recurrent Glioblastoma Clinical Trial page.